{{Rsnum
|rsid=75996173
|Chromosome=10
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=RET
|position=43114501
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=RET
}}{{omim
|id=164761
|rsnum=75996173
|variant=0004
}}{{ClinVar
|rsid=75996173
|Reversed=0
|FwdREF=G
|FwdALT=A,C,T
|REF=G
|ALT=A,C,T
|RSPOS=43609949
|CHROM=10
|dbSNPBuildID=131
|SSR=0
|SAO=3
|VP=0x050068000000000002110124
|GENEINFO=RET:5979
|GENE_NAME=RET
|GENE_ID=5979
|WGT=0
|VC=SNV
|CLNALLE=1; 2; 3
|CLNHGVS=NC_000010.10:g.43609949G>A; NC_000010.10:g.43609949G>C; NC_000010.10:g.43609949G>T
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=0; 1
|CLNSRCID=164761.0004; 164761.0005; 164761.0006
|CLNSIG=5
|CLNCUI=C0025268; C0031511,C0025268; C0031511,C0025268; C1833921; C0031511
|CLNDBN=Multiple endocrine neoplasia, type 2a; Pheochromocytoma; MEN2A and FMTC; Familial medullary thyroid carcinoma
|Disease=Multiple endocrine neoplasia; Pheochromocytoma; MEN2A and FMTC; Familial medullary thyroid carcinoma
|CLNACC=RCV000014924.20; RCV000014925.24; RCV000021823.1; RCV000014926.24; RCV000014927.24; RCV000021824.1; RCV000014928.20; RCV000014929.20; RCV000014930.20; RCV000021825.1
|Tags=PM;PMC;OTHERKG;LSD;OM;NOV
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet:Orphanet:SNOMED_CT; GeneReviews:MedGen:OMIM:Orphanet
|CLNDSDBID=NBK1257:C0025268:171400:247698:653:61808009; NBK1548:C0031511:171300:29072; NBK1257:C1833921:155240:653
}}{{PMID Auto
|PMID=3078962
|Title=Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
}}

{{PMID Auto
|PMID=7824936
|Title=Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.
}}

{{PMID Auto
|PMID=7907913
|Title=Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.
}}

{{PMID Auto
|PMID=12000816
|Title=Germ-line mutations in nonsyndromic pheochromocytoma.
}}